论文部分内容阅读
目的 观察东菱克栓酶对多发性脑梗塞急性期治疗效果。方法 6 6例急性脑梗塞分为多发性脑梗塞东菱克栓酶治疗组 (2 1例 ) ,单灶性脑梗塞东菱克栓酶治疗组 (2 0例 ) ,多发性脑梗塞低分子右旋糖酐治疗组 (2 5例 )。对各组治疗前后神经功能缺损评分进行统计学分析。结果 东菱克栓酶治疗组多发性脑梗塞的总有效率为 90 .5 % ,对轻症患者的疗效明显优于低分子右旋糖酐 (P<0 .0 1)。结论 东菱克栓酶是多发性脑梗塞的有效治疗药物
Objective To observe the curative effect of rhubarb thrombin on acute stage of multiple cerebral infarction. Methods Sixty-six patients with acute cerebral infarction were divided into multiple cerebral infarction groups (21 cases), monocrotaline group (20 cases), multiple cerebral infarction Dextran treatment group (25 cases). The scores of neurological deficits in each group before and after treatment were statistically analyzed. Results The total effective rate of multiple cerebral infarction was 90.5% in the treatment group and the therapeutic effect was obviously better than that of low molecular weight dextran in mild patients (P <0.01). Conclusion Batroxobin is an effective therapeutic agent for multiple cerebral infarction